so it turns out that ath434 works better than anticipated and also targets different areas. this could be significant in the battle against MSA and could posibly open up the doors for a more general scope in parkinsonian type of disorders.
if this is not value accretive, then i dont know what is!
Ann: ATH434 protects brain cells and improves motor function, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.125K | 824.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 64293651 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29230739 | 21 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |